Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a

Biogen Inc. (BIIB) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Biogen Inc. (BIIB) trades at a P/B ratio of 1.8×. Over the past ten years it has ranged from 1.0× (April 2025) to 10.4× (March 2015); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 5.0× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.4× 6.02%
FY2024 1.3× (49.11%)
FY2023 2.6× (11.54%)
FY2022 3.0× (9.35%)
FY2021 3.3× (11.47%)
FY2020 3.7× (11.42%)
FY2019 4.2× (12.03%)
FY2018 4.7× (16.10%)
FY2017 5.6× 7.36%
FY2016 5.3× (30.32%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.7× 17.02%
Mar 2026 1.4× 2.45%
Dec 2025 1.4× 25.21%
Sep 2025 1.1× 8.10%
42 more quarters

Against its own ten years

Low 1.0× High 10.4×
Ten-year median 3.8×
Current reading's percentile 19

P/B ratio against peers

Company P/B ratio
SNY Sanofi compare 1.2×
BIIB Biogen Inc. 1.8×
PFE Pfizer Inc. compare 2.0×
GSK GSK PLC Sponsored ADR compare 4.3×
NVO Novo Nordisk A/S compare 5.0×
AZN AstraZeneca PLC compare 5.1×
BMY Bristol Myers Squibb Company compare 5.5×
GILD Gilead Sciences, Inc. compare 16.5×
AMGN Amgen Inc. compare 20.0×
Drug Manufacturers General industry median 5.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on BIIB